The operations with use of minimal approaches not breaking substantially stability of the damaged spinal segment
and liquidating only local compression substrate are shown to the patients with the local forms of compressive lumbosacral radiculopathies in the wide interlaminar space and at young age.
One limitation of this study is the that center of rotation for axial rotation was evaluated without accounting for compression and shear forces; however, our data from the L spinal segments
do correlate with previous in vivo data placing the L center of rotation at the posterior portion of the intervertebral disc [19-20].
The results of posterior interbody spondylodesis with use of titanium cage in combination with autobone depended on the correct choice of surgical technique and adequacy of surgical intervention, directed to decompression of nervous-vascular formations and stabilization of spinal segment
Consistent with ASIA standards, clinical sensory level was determined separately for the right and left sides of the body and defined as the most caudal spinal segment
with normal sensory function for both sensory modalities (i.
The ReForm Pedicle Screw System is intended to provide immobilization and stabilization of spinal segments
in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar and sacral spine: degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor and failed previous fusion (pseudarthrosis).
The system is intended to provide immobilisation and stabilization of spinal segments
of skeletally mature patients as an adjunct to fusion in the treatment of the many acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine.
The CD HORIZON([R]) Fenestrated Screw Spinal System is intended to help provide immobilization and stabilization of spinal segments
as an adjunct to fusion of the thoracic, lumbar and/or sacral spine.
These drawbacks include the considerable blood loss leading to blood transfusions, neurologic deficit including spinal cord lesions, late infections, pseudoarthrosis, limitation of spinal motion also affecting non-fused levels, back pain and disc degeneration in the non-fused spinal segments
It provides stabilization and immobilisation of spinal segments
as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities.
Subjects eligible for the Phase I trial will have documented evidence of functionally complete (ASIA Impairment Scale grade A) spinal cord injury with a neurological level of T3 to T10 spinal segments
and agree to have GRNOPC1 injected into the lesion sites between 7 and 14 days after injury.
Patients eligible for the Phase I trial must have documented evidence of functionally complete spinal cord injury with a neurological level of T3 to T10 spinal segments
and agree to have GRNOPC1 injected into the lesion sites between seven and 14 days after injury.